- Home
- FPH vs PRTA Comparison
FPH vs PRTA Comparison
Compare FPH & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPH
- PRTA
- Stock Information
- Founded
- FPH 2009
- PRTA 2012
- Country
- FPH United States
- PRTA Ireland
- Employees
- FPH N/A
- PRTA N/A
- Industry
- FPH Real Estate
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- FPH Finance
- PRTA Health Care
- Exchange
- FPH Nasdaq
- PRTA Nasdaq
- Market Cap
- FPH 390.0M
- PRTA 472.1M
- IPO Year
- FPH 2017
- PRTA N/A
- Fundamental
- Price
- FPH $5.68
- PRTA $8.20
- Analyst Decision
- FPH
- PRTA Buy
- Analyst Count
- FPH 0
- PRTA 10
- Target Price
- FPH N/A
- PRTA $14.86
- AVG Volume (30 Days)
- FPH 150.3K
- PRTA 1.2M
- Earning Date
- FPH 10-16-2025
- PRTA 08-04-2025
- Dividend Yield
- FPH N/A
- PRTA N/A
- EPS Growth
- FPH 46.82
- PRTA N/A
- EPS
- FPH 1.08
- PRTA N/A
- Revenue
- FPH $197,429,000.00
- PRTA $10,341,000.00
- Revenue This Year
- FPH N/A
- PRTA N/A
- Revenue Next Year
- FPH N/A
- PRTA $389.77
- P/E Ratio
- FPH $5.28
- PRTA N/A
- Revenue Growth
- FPH N/A
- PRTA N/A
- 52 Week Low
- FPH $3.10
- PRTA $4.32
- 52 Week High
- FPH $6.71
- PRTA $22.83
- Technical
- Relative Strength Index (RSI)
- FPH 56.60
- PRTA 58.73
- Support Level
- FPH $5.51
- PRTA $8.05
- Resistance Level
- FPH $5.77
- PRTA $8.73
- Average True Range (ATR)
- FPH 0.14
- PRTA 0.38
- MACD
- FPH 0.04
- PRTA -0.05
- Stochastic Oscillator
- FPH 95.83
- PRTA 47.62
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.